BA
NVAX icon

BlackRock Advisors’s Novavax NVAX Stock Holding History

BlackRock Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$408K Buy
16,199
+82
+0.5% +$2.39K ﹤0.01% 2318
2016
Q3 		$670K Buy
16,117
+611
+4% +$78.9K ﹤0.01% 2029
2016
Q2 		$2.25M Buy
15,506
+1,729
+13% +$198K ﹤0.01% 1385
2016
Q1 		$1.42M Sell
13,777
-2,164
-14% -$232K ﹤0.01% 1588
2015
Q4 		$2.67M Sell
15,941
-14,320
-47% -$2.2M ﹤0.01% 1299
2015
Q3 		$4.28M Buy
30,261
+10,118
+50% +$2.27M ﹤0.01% 1141
2015
Q2 		$4.49M Buy
20,143
+8,469
+73% +$1.49M ﹤0.01% 1023
2015
Q1 		$1.93M Buy
11,674
+4,472
+62% +$726K ﹤0.01% 1249
2014
Q4 		$854K Buy
7,202
+355
+5% +$37.1K ﹤0.01% 1593
2014
Q3 		$571K Buy
6,847
+393
+6% +$35.5K ﹤0.01% 1865
2014
Q2 		$596K Sell
6,454
-43
-0.7% -$3.78K ﹤0.01% 1893
2014
Q1 		$589K Sell
6,497
-1,289
-17% -$144K ﹤0.01% 1932
2013
Q4 		$797K Buy
7,786
+2,373
+44% +$168K ﹤0.01% 1673
2013
Q3 		$341K Sell
5,413
-141,218
-96% -$7.95M ﹤0.01% 2189
2013
Q2 		$6.01M Buy
+146,631
New +$6.35M 0.01% 909

Other funds holding NVAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
QIM
Quantitative Investment Management Charlottesville, Virginia $963M AUM 12.95% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock Advisors's NVAX Position: Q4 2016 in Review

BlackRock Advisors increased its Novavax (NVAX) stake by 0.51% in Q4 2016, buying an estimated $2.39K and bringing the position to 16,199 shares worth $408K. The position accounts for ﹤0.01% of the portfolio, ranked #2318.

BlackRock Advisors first reported a position in NVAX in Q2 2013 and has held it in 15 quarters since. The position peaked at $6.01M in Q2 2013. 142 funds tracked by Wall St. Rank hold NVAX as of Q4 2016.

  • BlackRock Advisors held 16,199 shares of Novavax worth $408K as of Q4 2016.
  • BlackRock Advisors bought 82 Novavax shares in Q4 2016, an estimated $2.39K.
  • Novavax made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2318 holding.
  • BlackRock Advisors first reported a position in Novavax in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Novavax position peaked at $6.01M in Q2 2013.
  • 142 funds tracked by Wall St. Rank held Novavax as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.